Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 04-2022 | 04-2021 | 04-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,056 | 9,402 | 1,617 |
| Receivables | 319 | 210 | 251 |
| Inventories | 1,149 | N/A | N/A |
| TOTAL | $2,745 | $10,610 | $1,943 |
| Non-Current Assets | |||
| PPE Net | 356 | 681 | N/A |
| Intangibles | 934 | 2,931 | N/A |
| Other Non-Current Assets | 24 | 18 | 0 |
| TOTAL | $1,314 | $3,630 | $0 |
| Total Assets | $4,059 | $14,240 | $1,943 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 321 | N/A | N/A |
| Accrued Expenses | 66 | N/A | N/A |
| TOTAL | $608 | $715 | $41 |
| Non-Current Liabilities | |||
| TOTAL | $310 | $325 | $0 |
| Total Liabilities | $918 | $1,040 | $41 |
| Shareholders' Equity | |||
| Common Shares | 49,153 | 36,997 | 1,922 |
| Retained earnings | -52,865 | -30,421 | -41 |
| Other shareholders' equity | 6,278 | 6,117 | 20 |
| TOTAL | $3,141 | $13,200 | $1,901 |
| Total Liabilities And Equity | $4,059 | $14,240 | $1,943 |